7月 2026
- 首頁
- Recludix Pharma
7月 2026Recludix Pharma的市場佔有率分析
Advancing potent and selective inhibitors
for challenging protein targets Recludix is a clinical-stage company with leading, innovative platform approaches to discover and develop novel inhibitors for the toughest protein targets. The company’s management team includes industry veterans with a track record of success, including former leaders of Seagen, Blueprint Medicines, and Lilly. Recludix has developed […]
Recludix Pharma(包含公司地區)
查看更多網站流量與參與度資訊- recludixpharma.com
Recludix Pharma的熱門網域總造訪量
了解Recludix Pharma市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Recludix Pharma的熱門網域平均造訪時長
分析Recludix Pharma參與度指標。
過去 3 個月平均造訪時長
子公司細目
Recludix Pharma的熱門網域平均頁面瀏覽量
了解Recludix Pharma如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
使用的熱門技術Recludix Pharma
这些是Recludix Pharma顶级域名使用的行业网站技术
準備好開發優質潛在客戶了嗎?
借助 SimilarWeb 銷售情報解決方案,了解網站能使用哪些技術來完善銷售宣傳手法,並縮短銷售週期。
新聞與訊號來自Recludix Pharma
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Recludix Pharma, Inc. attended event European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) congresses on Jun 12th '26.Recludix Pharma to present preclinical asthma and dermatitis data for oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) congresses.
6月 12, 2026閱讀更多
新聞Recludix Pharma, Inc. attended event Society for Investigative Dermatology (SID) Annual Meeting on May 15th '26.SAN DIEGO, CA, May 15, 2026 - Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today presented preclinical data for REX-8756 demonstrating its potent preclinical efficacy and differentiated safety profile in a model of atopic dermatitis at the Society for Investigative Dermatology (SID) Annual Meeting.
5月 15, 2026閱讀更多
新聞Recludix Pharma, Inc. recognized as 2024 Fierce 15 biotech company.Recludix was named a 2024 Fierce 15 biotech company.
4月 30, 2026閱讀更多
查看所有Recludix Pharma信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
